Joint (NASDAQ:JYNT - Get Free Report) is projected to post its Q1 2025 quarterly earnings results after the market closes on Thursday, May 8th. Analysts expect Joint to post earnings of ($0.02) per share and revenue of $13.02 million for the quarter.
Joint Stock Performance
Shares of JYNT stock traded down $0.27 during mid-day trading on Tuesday, reaching $9.88. 49,328 shares of the company's stock traded hands, compared to its average volume of 55,644. Joint has a 12 month low of $9.58 and a 12 month high of $17.82. The firm has a 50 day moving average price of $11.08 and a two-hundred day moving average price of $11.12. The firm has a market capitalization of $151.39 million, a PE ratio of -8.67 and a beta of 1.45.
Analysts Set New Price Targets
Separately, StockNews.com downgraded shares of Joint from a "buy" rating to a "hold" rating in a research report on Monday, March 17th.
Get Our Latest Analysis on JYNT
Joint Company Profile
(
Get Free Report)
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Recommended Stories
Before you consider Joint, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Joint wasn't on the list.
While Joint currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
